Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Inission: The Power recovery continues - ABG

INISS BEksterne analyser14.10.2026, 07.07

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Q3e: Sales of SEK 580m and adj. EBITA margin of 7.3% (6.5%)
* Power recovery continues alongside EMS momentum
* Trading at 13/10x '26e/'28e P/E vs Nordic EMS peers

Q3 expectations

We expect Inission's order intake to continue to develop positively, for a R12m book-to-bill of 1.08 despite billings increasing in the last quarters, albeit at a slower pace than in H1. We expect Q3'26 sales of SEK 580m, up 9% y-o-y, driven by 7% organic growth and FX tailwinds of 2%. We forecast an adj. EBITA margin of 7.3% (6.5% Q3'25, 6.4% Q2'26). On a segment level, we expect Inission (EMS) sales of SEK 535m at a 7.0% adj. EBITA margin (7.6%) and Inission Power (OEM) sales of SEK 117m at a 4.0% margin (-7.4%), with Power's recovery continuing against weak comparables throughout H2. We expect defence and data centres to remain the strongest end-markets, consistent with the demand dynamics seen in H1. We note that larger defence orders tend to be project-driven, and some customers slowed in Q2 after a strong Q1, with activity expected to pick up and be supportive again in Q3. We do not expect the PCB disruptions in April and May to have a material impact on Q3, as Inission caught up on most of the shortfall in June and currently sees no further deterioration in lead times or prices.

Minor estimate changes

Following a change of analyst, we make only minor adjustments to segment margin assumptions, lowering '26e adj. EBITA by 0.6%.

Trading at 13/10x '26e/'28e P/E

The extensive order book, with average lead times of approximately six months, provides a reliable revenue visibility into H2. We continue to believe that there is upside to the guidance of monthly revenue of SEK 210-220 for FY26 sales of SEK 2,300-2,500m at a >6% adj. EBITA margin, with R12M sales of SEK 2,487m and a margin of 6.7%. We forecast SEK 2,599m at 6.8% for FY'26. The share is currently trading at 13/10x '26e/'28e P/E, versus Nordic EMS peers at 18x/14x.